NZSE:EBOHealthcare
Assessing EBOS Group’s Valuation After Robust Half Year Results And Distribution Centre Progress
Why EBOS Group’s latest half year result is getting attention
EBOS Group (NZSE:EBO) has landed on investor watchlists after its half year 2025 earnings update, with higher sales, higher net income and reaffirmed EBITDA guidance all arriving alongside a steady interim dividend.
See our latest analysis for EBOS Group.
Despite the solid half year update and the interim dividend of NZ$0.57 per share, EBOS Group’s share price has slipped to NZ$23.96, with a 30 day share price return of 6.81% and a...